Antipruritics - Administration & dosage
Research News and Information

Wednesday, March 10, 2010

A randomized controlled trial of pentazocine versus ondansetron for the treatment of intrathecal morphine-induced pruritus in patients undergoing cesarean delivery.

30 Oct 2009 BACKGROUND: Ondansetron is effective for the treatment of intrathecal morphine-induced pruritus. There is evidence that kappa-opioid receptor agonists have antipruritic activity. Pentazocine is an agonist of kappa-opioid receptors and partial ... Read more...

Potential toxicity of chlorpheniramine plus chloroquine for the treatment of childhood malaria.

30 Aug 2009 OBJECTIVES: To compare the adverse effects of two regimens of chlorpheniramine plus chloroquine (CP+CQ) in children who live in a country where chloroquine resistant malaria is endemic. METHODS: 99 children with acute uncomplicated malaria were ... Read more...

Participation of proteinase-activated receptor-2 in passive cutaneous anaphylaxis-induced scratching behavior and the inhibitory effect of tacrolimus.

29 Jun 2009 Proteinase-activated receptor-2 (PAR2) may be an important regulator of skin mast cell function during cutaneous inflammation and hypersensitivity. However, little is known of the role of PAR2 in allergic pruritus, because mast cells, which are ... Read more...

Latest indexed articles for 'Antipruritics - Administration & dosage'

These are the very latest articles for this heading:

• A randomized controlled trial of pentazocine versus ondansetron for the treatment of intrathecal morphine-induced pruritus in patients undergoing cesarean delivery. 30 Oct 2009
• Potential toxicity of chlorpheniramine plus chloroquine for the treatment of childhood malaria. 30 Aug 2009
• Participation of proteinase-activated receptor-2 in passive cutaneous anaphylaxis-induced scratching behavior and the inhibitory effect of tacrolimus. 29 Jun 2009
• [Antipruritic efficacy of a high-dosage antihistamine therapy. Results of a retrospectively analysed case series] 29 Jun 2009
• Skin disposition of d-camphor and l-menthol alone and together. 29 Apr 2009
• Case for diagnosis: (unilateral multiple piloleiomyoma). 27 Feb 2009
• An evaluation of prescription device moisturizers. 27 Feb 2009
• Churg-Strauss syndrome in a child with IgA nephropathy. 27 Feb 2009
• Successful treatment of therapy-resistant pruritus in lichen amyloidosis with menthol. 30 Dec 2008
• The basis of topical superoxide dismutase antipruritic activity. 30 Dec 2008
• Topical anti-inflammatory and antipruritic effects of Alpinia katsumadai extracts. Sep 2008
• Impact of menthol inhalation on nasal mucosal temperature and nasal patency. 29 Jun 2008
• Preoperative gabapentin prevents intrathecal morphine-induced pruritus after orthopedic surgery. 30 May 2008
• Antipruritic effect of cyclosporine microemulsion in prurigo nodularis: results of a case series. 26 Apr 2008
• Successful treatment of genital pruritus using topical immunomodulators as a single therapy in multi-morbid patients. 30 Dec 2007
• Case of allergic contact dermatitis due to a topical agent containing chlorpheniramine maleate, with a false-negative patch test. 30 Dec 2007
• Oral administration of bepotastine besilate suppressed scratching behavior of atopic dermatitis model NC/Nga mice. 11 Nov 2007
• Application of menthol to the skin of whole trunk in mice induces autonomic and behavioral heat-gain responses. 27 Aug 2007
• Bilateral facial pigmentation. 11 Jul 2007
• The antipruritic and antiemetic effects of epidural droperidol: a study of three methods of administration. 29 Jun 2007

See a longer list of these articles.

Technical information about 'Antipruritics'

Definition: Agents, usually topical, that relieve itching (pruritus).

Registry Number: 0

Descriptor UI: D000982

Alternative terms: Antipruritics; Antipruritic Drugs; Drugs, Antipruritic; Antipruritic Agents; Agents, Antipruritic;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Tree Number: D27.505.954.444.075;

Online Note: search DERMATOLOGIC AGENTS 1967-74

History Note: 91(75); was see under DERMATOLOGIC AGENTS 1975-90

Technical Notes: GEN or unspecified; prefer specifics; D25-26 qualif; consider also PRURITUS /drug ther